trodelvy
(SACITUZUMAB GOVITECAN)Gilead Sciences
Usage: TRODELVY is indicated for treating adults with unresectable locally advanced or metastatic triple-negative breast cancer and certain hormone receptor-positive breast cancers after multiple systemic therapies. It also treats locally advanced or metastatic urothelial cancer in patients previously treated with platinum-based chemotherapy and PD-1/PD-L1 inhibitors.